000 | 01940 a2200505 4500 | ||
---|---|---|---|
005 | 20250517023101.0 | ||
264 | 0 | _c20160120 | |
008 | 201601s 0 0 eng d | ||
022 | _a1872-6240 | ||
024 | 7 |
_a10.1016/j.brainres.2015.03.024 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYin, Bo | |
245 | 0 | 0 |
_aInhibition of receptor-interacting protein 3 upregulation and nuclear translocation involved in Necrostatin-1 protection against hippocampal neuronal programmed necrosis induced by ischemia/reperfusion injury. _h[electronic resource] |
260 |
_bBrain research _cJun 2015 |
||
300 |
_a63-71 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
650 | 0 | 4 |
_aCA1 Region, Hippocampal _xdrug effects |
650 | 0 | 4 |
_aCathepsin B _xmetabolism |
650 | 0 | 4 |
_aCell Death _xdrug effects |
650 | 0 | 4 |
_aCytoplasm _xdrug effects |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aImidazoles _xpharmacology |
650 | 0 | 4 |
_aIndoles _xpharmacology |
650 | 0 | 4 |
_aLysosomes _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNecrosis _xdrug therapy |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
650 | 0 | 4 | _aPoly (ADP-Ribose) Polymerase-1 |
650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerases _xmetabolism |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xmetabolism |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptor-Interacting Protein Serine-Threonine Kinases _xmetabolism |
650 | 0 | 4 |
_aReperfusion Injury _xdrug therapy |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
700 | 1 | _aXu, Yang | |
700 | 1 | _aWei, Rui-Li | |
700 | 1 | _aHe, Fangping | |
700 | 1 | _aLuo, Ben-Yan | |
700 | 1 | _aWang, Jing-Ye | |
773 | 0 |
_tBrain research _gvol. 1609 _gp. 63-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2015.03.024 _zAvailable from publisher's website |
999 |
_c24734576 _d24734576 |